RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
119 hedge funds and large institutions have $1.14B invested in Ra Pharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 27 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
+1
Holders Change %
+0.85%
% of All Funds
2.61%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
17
Increased
59
Reduced
27
Closed
16
Calls
$359K
Puts
$499K
Net Calls
-$140K
Net Calls Change
+$1.41M
Top Buyers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$51.8M |
| 2 |
2
AllianceBernstein
Nashville,
Tennessee
|
$18.3M |
| 3 |
PC
3
Polar Capital
London,
United Kingdom
|
$15.3M |
| 4 |
4
BlackRock
New York
|
$111M |
| 5 |
BBA
5
Baker Bros. Advisors
New York
|
$55.5M |
